SARA DERINGER-KOHORST: Open Payments
NPI 1962740266 · OVID, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$352 in 18 payments from 9 companies in 2025. Trend: 2023 $128 · 2024 $244 · 2025 $352
Food & beverage: $352
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $85 |
| Novo Nordisk Inc | 3 | $66 |
| Otsuka America Pharmaceutical, Inc. | 2 | $53 |
| Kowa Pharmaceuticals America, Inc. | 3 | $44 |
| Amgen Inc. | 2 | $32 |
| Axsome Therapeutics, Inc. | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $16 |
| Lilly USA, LLC | 1 | $14 |
Products named: QULIPTA, REXULTI, ZORYVE, OTEZLA, VRAYLAR, Rybelsus, Auvelity, AIRSUPRA.
Industry payments across MI — which companies pay providers there.
